대한한방내과학회지 (The Journal of Internal Korean Medicine)

대한한방내과학회 (The Society of Internal Korean Medicine)
권호 표지
DOI QR코드

DOI QR Code

비알코올성 지방간 환자의 간기능 개선

A Case Report of a Non-Alcoholic Fatty Liver Disease Patient Treated With Chunggan-tang

  • 권기현 (동서한방병원 한방내과) ;
  • 오서혜 (동서한방병원 한방내과) ;
  • 송금주 (동서한방병원 한방신경정신과) ;
  • 김상범 (동서한방병원 한방신경정신과) ;
  • 이형우 (동서한방병원 한방신경정신과) ;
  • 신현수 (동서한방병원 한방내과)
  • Gwon, Gi-hyeon (Dept. of Oriental Internal Medicine, Dong-Seo Oriental Medicine Hospital) ;
  • Oh, Seo-hye (Dept. of Oriental Internal Medicine, Dong-Seo Oriental Medicine Hospital) ;
  • Song, Geum-ju (Dept. of Oriental Neuropsychiatry, Dong-Seo Oriental Medicine Hospital) ;
  • Kim, Sang-beom (Dept. of Oriental Neuropsychiatry, Dong-Seo Oriental Medicine Hospital) ;
  • Lee, Hyung-woo (Dept. of Oriental Neuropsychiatry, Dong-Seo Oriental Medicine Hospital) ;
  • Shin, Hyeon-su (Dept. of Oriental Internal Medicine, Dong-Seo Oriental Medicine Hospital)
  • 투고 : 2020.09.04
  • 심사 : 2020.11.02
  • 발행 : 2020.10.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective: The aim of this study was to report on the effectiveness of Chunggan-tang in a patient with non-alcoholic fatty liver disease. Methods: A 57-year-old woman diagnosed with non-alcoholic fatty liver disease took Chunggan-tang from March 27. 2019 to April 3. 2019. We observed her laboratory findings. Results: After treatment, her laboratory findings showed a reduction in liver enzyme levels. Conclusion: This study shows that Chunggan-tang may be an effective treatment for non-alcoholic fatty liver disease.

키워드

참고문헌

  1. Yoon SK. Diagnosis and treatment of fatty liver. Korean J medicine 2009;76(6):677-9.
  2. Liver System Association of Internal Medicine. Liver System of Internal Medicine. 5th ed. Seoul: Nado; 2013, p. 38, 321-5.
  3. Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 2006;40(Suppl 1):S5-10.
  4. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am J Gastroenterol 2012;107:811-26. https://doi.org/10.1038/ajg.2012.128
  5. Caturelli E, Squillatne MM, Andriulli A, Rapaccini GL. Hypoechoic lesions in the 'bright liver' : A reliable indicator of fatty change. A prospective study. J Gastroenterol Hepatol 1992;7(5):469-72. https://doi.org/10.1111/j.1440-1746.1992.tb01022.x
  6. 김병운. 만성간염 3,316례에 대한 임상분석과 生肝健脾湯의 치료효과. 대한한의학회지 1993;14(1):216-23.
  7. 김병운. 간염환자치료례의 응용. 서울: 의림사; 1984, p. 21-2.
  8. Sim JS, Kim KS, Kang DG, Kim GS. A Case Report on the Hepatic Encephalopathy. The Journal of Korean Oriental Internal Medicine 2002;23(4):695-701.
  9. 윤용갑. 동의방제와 처방해설. 서울: 의성당; 1998, p. 274-5.
  10. 전국한의과대학 본초학공동교재 편집위원회. 본초학. 2012.